| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 3 | |
| #2 | China | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Argentina | 2 | |
| #5 | Brazil | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Mexico | 2 | |
| #8 | Singapore | 2 | |
| #9 | Australia | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Leriche Caroline | 8 |
| #2 | Latour Elisabeth | 7 |
| #3 | Auclair Eric | 6 |
| #4 | Le Roux Jacques | 6 |
| #5 | Middlemiss David | 6 |
| #6 | Takruri Harun | 5 |
| #7 | Combal Jean Philippe | 5 |
| #8 | Middlemiss David N | 3 |
| #9 | Bonnel Sebastien | 3 |
| #10 | Combal Jean-Philippe | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2011211410A1 | [1,2,4] triazolo [1,5-A] pyridines as kinase inhibitors | |
| WO2010092041A1 | [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors | |
| CA2651194A1 | Methods for treating neovascular diseases |